Skip to contentA
Abeona Therapeutics Inc.
A
ABEOAbeona Therapeutics Inc. ABEO Q4 2012 · Abeona Therapeutics Inc. · ThalerReleased Mar 19, 2013, after the close
10-K filed Mar 20, 2013, 79 days after period end · 0000318306-13-000004
Q4 2012 · 10-K
derived · Computed from the longer spans the company filed.
Revenue$1.01M$1.01Mderived+102.0% vs Q4 2011 No earnings release is on file for this quarter. Its figures came with the 10-K.
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Abeona Therapeutics Inc. · CIK 318306 · Engraved from SEC EDGAR
+15.5% vs Q3 2012
Net Income$19.83M$19.83Mderived+6,955.9% vs Q4 2011N/M vs Q3 2012 EPS, diluted—Not derived. Share counts vary by quarter.
Operating Incomederived-$1,219,000N/M Operating Cash Flowderived-$1,616,000N/M Free Cash Flowderived-$1,614,000N/M Margins · derivedOperating margin-121.2%+218.2 pt vs Q4 2011
Net margin1970.9%+1914.4 pt vs Q4 2011
ended Dec 31, 2012 · filed Mar 20, 2013 · 79 d after period end